40 results on '"Buzzigoli, Emma"'
Search Results
2. Biomonitoring of Bis(2-ethylhexyl)phthalate (DEHP) in Italian children and adolescents: Data from LIFE PERSUADED project
Catalog
Books, media, physical & digital resources
3. The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases
4. Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
5. Peripheral Insulin Resistance Predicts Liver Damage in Nondiabetic Subjects With Nonalcoholic Fatty Liver Disease
6. Metabolomic analysis identifies new biomarkers of liver damage in NAFLD: 60
7. Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients
8. Changes in Plasma Bioactive Lipids and Inflammatory Markers during a Half-Marathon in Trained Athletes
9. Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects
10. Quantification of Liver Glucose Metabolism by Positron Emission Tomography: Validation Study in Pigs
11. Metabolic handling of an oral fat load in NAFLD patients: 98
12. Effects of Adding Exercise to a 16-Week Very Low-Calorie Diet in Obese, Insulin-Dependent Type 2 Diabetes Mellitus Patients
13. Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease
14. Circulating Soluble Receptor for Advanced Glycation End Products Is Inversely Associated with Glycemic Control and S100A12 Protein
15. The Effect of Pioglitazone on the Liver: Role of adiponectin
16. Restoration of Hepatic Autoregulation by Pioglitazone in Type 2 Diabetic Patients: Role of Adiponectin?: 1513-P
17. Separate Contribution of Diabetes, Total Fat Mass, and Fat Topography to Glucose Production, Gluconeogenesis, and Glycogenolysis
18. Healthy aging: the INTECMAN project
19. Insulin secretion and decreased glucose clearance are associated with enhanced fibrogenesis and a high risk of disease progression in non-diabetic patients with Non Alcoholic Fatty Liver Disease
20. Glucokinase links krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in non-alcoholic fatty liver disease
21. The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF
22. Author Correction: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
23. Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
24. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
25. Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters
26. Oxidative stress-inducible factors promote liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease
27. The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases.
28. Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease
29. Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
30. Visceral Fat in Hypertension
31. 18F-FDG Assessment of Glucose Disposal and Production Rates During Fasting and Insulin Stimulation: A Validation Study.
32. Metabolomic analysis identifies new biomarkers of liver damage in NAFLD
33. Metabolic handling of an oral fat load in NAFLD patients
34. Validation of surrogate indexes of peripheral and hepatic insulin resistance and evaluation of their utility as non-invasive predictors of histological features in patients with Non-Alcoholic Fatty Liver Disease
35. Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile
36. Plasma Selenoprotein P levels are related to adipose tissue insulin resistance, composition of free fatty acids and liver fibrosis in non-diabetic patients with Non Alcoholic Fatty Liver Disease
37. Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alcoholic Fatty Liver Disease
38. The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF
39. Cardiometabolic risk and subclinical vascular damage assessment in idiopathic inflammatory myopathies: a challenge for the clinician.
40. 18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.